CUPR
Cuprina Holdings (Cayman) Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$1.90
+1.60%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.90
From 52W high−77.41%
Volume154533.00
Market cap$13.31M
P/E (TTM)—
P/S (TTM)269.5x
Div yield—
Key dataNov 4, 2026
Open
$1.90
From 52W high
−77.41%
Volume
154533.00
Market cap
$13.31M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
P/E (TTM)
—
RSI (14)
46.0
MomentumView details →
1D Return
+1.60%
YTD Return
−40.63%
SummaryUpdated Dec 1, 2025
Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) is a Singapore-based biomedical and biotechnology company that went public in April 2025. Founded as a specialized developer of innovative wound care solutions, the company has positioned itself at the intersection of biotechnology and medical device manufacturing. Cuprina operates primarily in the chronic wound management sector, developing and commercializing biological products for healthcare applications, while also maintaining a presence in the cosmeceutical market.
Similar companies
Latest newsMore news →
Cuprina Holdings (Cayman) Limited, through its subsidiary Cuprina Holdings (BVI) Limited, entered into Sale and Purchase Agreements to acquire the entire issued share capital of East Coast Podiatry Centre Pte. Ltd. and Orchard Clinic Management Pte. Ltd. in Singapore.33d agoCuprina Holdings (Cayman) Limited closed a public offering of 4,322,489 Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds.48d ago